THE ECONOMIC IMPACT OF RHEUMATOID ARTHRITIS ON PATIENTS’ HOUSEHOLDS. AN ESTIMATION OF THE DISEASE RELATED CATASTROPHIC HEALTH EXPENDITURE, IN GREECE
Author(s)
Skroumpelos A1, Naoum P2, Athanasakis K2, Argyropoulos E3, Koutsogianni A4, Pavi E2, Kyriopoulos J2
1Roche (Hellas) S.A., Athens, Greece, 2National School of Public Health, Athens, Greece, 3Roche Hellas, Athens, Greece, 4Arthritis Foundation of Crete, Heraklion, Greece
OBJECTIVES: As a chronic condition rheumatoid arthritis (RA) is related with significant life time health care expenditure a share of which, is estimated to burden the patient and the household. Aim of this study is to estimate the private health expenditure of patients with RA and its impact on patient’s household. METHODS: : A telephone survey took place during which patients with RA were asked to provide with information regarding their out-of-pocket, medical and non-medical, expenditures for the management of their disease, six months prior the telephone interview. Patients were recruited through the relevant patients associations. Catastrophic health expenditure (CHE) was defined as any amount spent for health which accounts for more than 20% of the total household income RESULTS: CONCLUSIONS: RA patients spent annually more than their household per capita monthly income for the management of their disease. This expenditure appears to be a significant burden for 11.6% of the patients or for more than 4,000 households, based on the prevalence of the disease in Greece. In this context, health and social policy interventions should be adopted in order to control private health expenditure and/or prevent households from being subject to CHE.
Conference/Value in Health Info
2017-11, ISPOR Europe 2017, Glasgow, Scotland
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PMS99
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Musculoskeletal Disorders